CO5261594A1 - MYT1 CINASA INHIBITORS - Google Patents

MYT1 CINASA INHIBITORS

Info

Publication number
CO5261594A1
CO5261594A1 CO01015772A CO01015772A CO5261594A1 CO 5261594 A1 CO5261594 A1 CO 5261594A1 CO 01015772 A CO01015772 A CO 01015772A CO 01015772 A CO01015772 A CO 01015772A CO 5261594 A1 CO5261594 A1 CO 5261594A1
Authority
CO
Colombia
Prior art keywords
substituted
unsubstituted
aryl
group
heteroaryl
Prior art date
Application number
CO01015772A
Other languages
Spanish (es)
Inventor
Maria A Lago
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of CO5261594A1 publication Critical patent/CO5261594A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Un compuesto de Fórmula (I), más abajo:<EMI FILE="01015772_1" ID="1" IMF=JPEG >en la que X e Y se seleccionan, independientemente, del grupo que consta de H, Br, CI, CH3, NO2, CN, NR1R2, C=ONR1R2MeO, HO, Me, OR; y un anillo arílico o heteroarílico sustituido independientemente con X e Y;R representa H o alquilo inferior;R1 y R2 se seleccionan independientemente del grupo que consta de H, alquilo inferior, sustituido o no sustituido con X, y un anillo aromático o heterocíclico, sustituido o no sustituido con Y y X;A se selecciona del grupo que consta de O, = O, =NR, =N-NHR3, =NH-NH-CS-NH2, y =NH-NH-CO-NH2; o A es alquilo inferior, sustituido o no sustituido con X, anillo arílico o heteroarílico;o A es un anillo heterocíclico; yR3 se selecciona del grupo que consta de R1, arilo, heteroarilo, C=OR1, C = O-arilo yC=O-heteroarilo, sustituido o no sustituido con X e Y.Un método para antagonizar un receptor de myt1 cinasa que comprende administrar al sujeto que lo necesite una cantidad eficaz de un compuesto según la reivindicación 1.A compound of Formula (I), below: <EMI FILE = "01015772_1" ID = "1" MFI = JPEG> in which X and Y are independently selected from the group consisting of H, Br, CI, CH3 , NO2, CN, NR1R2, C = ONR1R2MeO, HO, Me, OR; and an aryl or heteroaryl ring independently substituted with X and Y; R represents H or lower alkyl; R1 and R2 are independently selected from the group consisting of H, lower alkyl, substituted or unsubstituted with X, and an aromatic or heterocyclic ring, substituted or unsubstituted with Y and X; A is selected from the group consisting of O, = O, = NR, = N-NHR3, = NH-NH-CS-NH2, and = NH-NH-CO-NH2; or A is lower alkyl, substituted or unsubstituted with X, aryl or heteroaryl ring, or A is a heterocyclic ring; and R3 is selected from the group consisting of R1, aryl, heteroaryl, C = OR1, C = O-aryl and C = O-heteroaryl, substituted or unsubstituted with X and Y. A method for antagonizing a myt1 kinase receptor comprising administering to the subject in need an effective amount of a compound according to claim 1.

CO01015772A 2000-03-02 2001-02-28 MYT1 CINASA INHIBITORS CO5261594A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US18653200P 2000-03-02 2000-03-02

Publications (1)

Publication Number Publication Date
CO5261594A1 true CO5261594A1 (en) 2003-03-31

Family

ID=22685317

Family Applications (1)

Application Number Title Priority Date Filing Date
CO01015772A CO5261594A1 (en) 2000-03-02 2001-02-28 MYT1 CINASA INHIBITORS

Country Status (3)

Country Link
AU (1) AU2001241917A1 (en)
CO (1) CO5261594A1 (en)
WO (1) WO2001064680A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7423031B2 (en) 2003-05-01 2008-09-09 Irm Llc Compounds and compositions as protein kinase inhibitors
WO2004103958A2 (en) * 2003-05-19 2004-12-02 Michigan State University Preparation of hymenialdisine derivatives and use thereof
MX2010007430A (en) 2008-01-11 2010-12-21 Albany Molecular Res Inc (1-azinone) -substituted pyridoindoles as mch antagonists.
US9073925B2 (en) 2009-07-01 2015-07-07 Albany Molecular Research, Inc. Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereof
WO2011003012A1 (en) 2009-07-01 2011-01-06 Albany Molecular Research, Inc. Azinone-substituted azapolycycle mch-1 antagonists, methods of making, and use thereof
EP2448585B1 (en) 2009-07-01 2014-01-01 Albany Molecular Research, Inc. Azinone-substituted azepino[b]indole and pyrido-pyrrolo-azepine mch-1 antagonists, methods of making, and use thereof
WO2011003007A1 (en) 2009-07-01 2011-01-06 Albany Molecular Research, Inc. Azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof
WO2012088038A2 (en) 2010-12-21 2012-06-28 Albany Molecular Research, Inc. Piperazinone-substituted tetrahydro-carboline mch-1 antagonists, methods of making, and uses thereof
WO2012088124A2 (en) 2010-12-21 2012-06-28 Albany Molecular Research, Inc. Tetrahydro-azacarboline mch-1 antagonists, methods of making, and uses thereof
CA3177200A1 (en) * 2020-04-01 2021-10-07 Repare Therapeutics Inc. Compounds, pharmaceutical compositions, and methods of preparing compounds and of their use
CN115811976A (en) * 2020-04-01 2023-03-17 修复治疗公司 Methods of using MYT1 inhibitors
CN115806555B (en) * 2021-09-16 2024-05-28 南开大学 Indoloazepinone derivatives, their preparation and their use for controlling plant viruses, for killing parasites and for killing bacteria
WO2024104282A1 (en) * 2022-11-14 2024-05-23 捷思英达控股有限公司 1h-pyrrolo[2,3-b]pyridine derivative, preparation method therefor, and use thereof in medicine
WO2024166131A1 (en) * 2023-02-09 2024-08-15 Satyarx Pharma Innovations Private Limited Heteroaryl compounds as pkmyt1 inhibitors
WO2024179948A1 (en) * 2023-02-28 2024-09-06 F. Hoffmann-La Roche Ag Indazole compounds as pkmyt1 kinase inhibitors

Also Published As

Publication number Publication date
AU2001241917A1 (en) 2001-09-12
WO2001064680A1 (en) 2001-09-07

Similar Documents

Publication Publication Date Title
CO5261594A1 (en) MYT1 CINASA INHIBITORS
CO5280070A1 (en) COMPOUNDS, PHARMACEUTICAL COMPOSITIONS OF INDAZOL AND METHODS TO MEASURE OR INHIBIT THE CELL PROLIFERATION
CO5390047A1 (en) DERIVATIVES OF UK-2A
CO5261539A1 (en) PHARMACEUTICALLY ACTIVE COMPOUNDS
CO5271657A1 (en) DERIVATIVES OF AZAINDOL
CO5200785A1 (en) THERAPEUTIC USE OF QUINAZOLINE
CO5140093A1 (en) MODIFIED EPOTILONES C 21
EA200101232A1 (en) PHENOXYPROPYLAMINE COMPOUNDS
CO5180626A1 (en) PURINE DERIVATIVES PROTEIN QUINASA SYK INHIBITORS
AR006906A1 (en) SUBSTITUTED INDAZOL DERIVATIVES, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM, USE OF THEM AND INTERMEDIARIES OF SYNTHESIS
EA200300354A1 (en) Quinoline derivatives as tyrosine kinase inhibitors
CO5170512A1 (en) TETRAHYDROQUINOLIN PIPERIDINE DERIVATIVES
CO5180629A1 (en) PYRIMIDINE-2,4,6-METALOPROTEINASE INHIBITING TTRIONS
CO5640098A2 (en) BIARILOXIMETILAREN-CARBOXILIC ACIDS
EA200300674A1 (en) OBTAINING HETEROCYCLIC SULPHONAMIDE INHIBITORS BETA-AMYLOID
CO5180605A1 (en) INDOL COMPOUNDS
ES2188194T3 (en) 1,8-NAFTIRIDIN-4 (1H) -ONON REPLACED AS INHIBITORS OF PHOSPHODESTERASE 4.
CO5271675A1 (en) DECAHIDRO-ISOQUINOLINAS DERIVATIVES, PROCESS FOR THE PREPARATION, COMPOSITION AND PHARMACEUTICAL COMPOUNDS CONTAINING THEM
UY26048A1 (en) DERIVATIVES OF PIRIDOPIRANOACEPINAS, ITS PREPARATION AND ITS THERAPEUTIC APPLICATION
CO5271716A1 (en) CRYSTALS OF 4- CARBOXAMINE 1,2,3,4-TETRAHYDROQUINOLINE 2- REPLACED
CO5090829A1 (en) ORGANIC COMPOUNDS OF FORMULA I, USED AS INHIBITED RES OF THE PROTEIN OF TRANSFER OF MICROSOUS TRIGLICERIDE AND OF THE APOLIPOPROTEIN B SECRETION.
CO5420196A1 (en) INHIBITING COMPOUNDS OF METALOPROTEASE BIDENTS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND METHODS FOR USE
BRPI0407841A (en) heterocyclic kinase inhibitors
CO5261565A1 (en) INHIBITORS OF N- (5 - (((5-RENT-2-OXAZOLIL) METHYL) TIO) -2-TIAZOLIL) -CARBOXAMIDE OF CYCLINE DEPENDENT KINASES
SV2002000244A (en) METHODS AND COMPOUNDS TO INHIBIT MRP1 REF.X-13353

Legal Events

Date Code Title Description
FA Application withdrawn